Understanding individual muscle strength is crucial for optimizing physical therapy and enhancing athletic performance. Traditional methods, however, often fall short in precision. The newly ...

– Demonstrated potential of FSHD-TUG and Emerald in-home assessments as accurate, low-burden clinical assessments of mobility for FSHD patients – – Company on track to report data from Phase 2b ReDUX4 ...

LINKÖPING, Sweden, Dec. 2, 2021 /PRNewswire/ -- AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research ...

Boston – Researchers from Dana-Farber Cancer Institute have found a way to use artificial intelligence (AI) to diagnose muscle wasting, called sarcopenia, in patients with head and neck cancer. AI ...

– DemonstratedWhole-Body MRI captures heterogeneity and provides key disease severity and progression information correlated with FSHD clinical endpoints – – Demonstrated potential of FSHD-TUG and ...